Suppr超能文献

一名长期使用环磷酰胺的80岁男性的肺动脉高压。

Pulmonary arterial hypertension in an 80-year-old man with long-term use of cyclophosphamide.

作者信息

Suzuki Takatoshi, Tsujino Ichizo, Harabayashi Wataru, Shima Hideki, Nakamura Junichi, Sato Takahiro, Suzuki Masaru, Takeda Yukari, Konno Satohi

机构信息

Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, N15, W7, Kita-ku, Sapporo, 060-8638, Japan.

Department of Hematology, Tonan Hospital, N4, W7, Kita-ku, Sapporo, 060-0004, Japan.

出版信息

Respir Med Case Rep. 2023 May 11;44:101867. doi: 10.1016/j.rmcr.2023.101867. eCollection 2023.

Abstract

An 80-year-old man diagnosed with primary macroglobulinemia 7 years earlier had been treated with cyclophosphamide, following which he developed dyspnea on exertion. Cyclophosphamide was discontinued. The patient's dyspnea, however, failed to improve. Right heart catheterization (RHC) revealed precapillary pulmonary hypertension (PH). He was transferred to our institution for further examination. Prior use of cyclophosphamide was the patient's only risk factor for PH, and cyclophosphamide use was considered as a possible cause of PH in this case. He was treated with tadalafil and dyspnea gradually improved. A follow-up RHC exhibited improvement in mean pulmonary arterial pressure and pulmonary vascular resistance.

摘要

一名80岁男性,7年前被诊断为原发性巨球蛋白血症,曾接受环磷酰胺治疗,之后出现劳力性呼吸困难。停用环磷酰胺后,患者的呼吸困难仍未改善。右心导管检查(RHC)显示毛细血管前性肺动脉高压(PH)。他被转至我院作进一步检查。既往使用环磷酰胺是该患者发生PH的唯一危险因素,在本病例中,使用环磷酰胺被认为是PH的可能病因。他接受了他达拉非治疗,呼吸困难逐渐改善。随访的右心导管检查显示平均肺动脉压和肺血管阻力有所改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e3/10203762/5cbc8375dfc0/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验